Name
rrtslope
Label
Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Description

PVT QC Rules 3-25-09 FINAL

Type
numeric
Visit (Number) vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
N Mean StdDev Median Min Max Unknown Total
Baseline (BL) - - - - - - 1,516 1,516
Clinical Evaluation (CE) - - - - - - 1,516 1,516
Diagnostic Visit (DX) 1,199 -2.2 ± 44.4 -0.02 -888.0 0.2 317 1,516
CPAP Titration Visit (CPAP) - - - - - - 1,516 1,516
Two Month Post-CPAP Neurocognitive Visit (2M) 877 -1.0 ± 30.0 -0.02 -888.0 0.1 639 1,516
Four Month Post-CPAP Neurocognitive Visit (4M) - - - - - - 1,516 1,516
Six Month Post-CPAP Neurocognitive Visit (6M) 848 -1.1 ± 30.5 -0.02 -888.0 0.1 668 1,516
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,199 -2.2 ± 44.4 -0.02 -888.0 0.2 317 1,516
Male 767 -2.3 ± 45.3 -0.02 -888.0 0.1 191 958
Female 432 -2.1 ± 42.7 -0.02 -888.0 0.2 126 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 877 -1.0 ± 30.0 -0.02 -888.0 0.1 639 1,516
Male 569 -0.03 ± 0.04 -0.02 -0.2 0.1 389 958
Female 308 -2.9 ± 50.6 -0.02 -888.0 0.09 250 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 848 -1.1 ± 30.5 -0.02 -888.0 0.1 668 1,516
Male 550 -0.03 ± 0.04 -0.02 -0.2 0.1 408 958
Female 298 -3.0 ± 51.4 -0.03 -888.0 0.09 260 558
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,199 -2.2 ± 44.4 -0.02 -888.0 0.2 317 1,516
Native American 20 -0.02 ± 0.04 -0.01 -0.09 0.07 8 28
Asian 71 -0.03 ± 0.04 -0.03 -0.1 0.09 18 89
Black 115 -0.03 ± 0.05 -0.02 -0.2 0.1 57 172
Hispanic 83 -0.03 ± 0.05 -0.02 -0.2 0.1 33 116
White 902 -3.0 ± 51.2 -0.02 -888.0 0.2 200 1,102
Other 8 -0.02 ± 0.04 -0.008 -0.09 0.02 1 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 877 -1.0 ± 30.0 -0.02 -888.0 0.1 639 1,516
Native American 13 -0.05 ± 0.04 -0.05 -0.1 0.03 15 28
Asian 48 -0.03 ± 0.05 -0.02 -0.2 0.06 41 89
Black 76 -11.7 ± 101.9 -0.03 -888.0 0.1 96 172
Hispanic 65 -0.03 ± 0.05 -0.02 -0.2 0.1 51 116
White 672 -0.03 ± 0.04 -0.02 -0.2 0.1 430 1,102
Other 3 -0.03 ± 0.04 -0.05 -0.06 0.006 6 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Slope of the time on task vigilance decrement function (for 1/RT data)
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 848 -1.1 ± 30.5 -0.02 -888.0 0.1 668 1,516
Native American 13 -0.05 ± 0.05 -0.03 -0.1 0.01 15 28
Asian 50 -0.05 ± 0.04 -0.05 -0.1 0.03 39 89
Black 75 -0.04 ± 0.05 -0.03 -0.2 0.07 97 172
Hispanic 61 -0.04 ± 0.05 -0.03 -0.3 0.05 55 116
White 646 -1.4 ± 34.9 -0.02 -888.0 0.1 456 1,102
Other 3 0.02 ± 0.05 0.01 -0.03 0.07 6 9